Investor's Business Daily on MSN
Caterpillar, IBD stock of the day, rises in buy zone amid data center strength
U.S. industrial stocks are having a moment.
Celltrion, Inc. today announced that seven abstracts will be presented at the 2026 Digestive Disease Week® (DDW) Annual Meeting, taking place May 2-5 in Chicago, Illinois. The oral and poster ...
Investor's Business Daily on MSN
Stock market leaders emerge in IBD 50, rise in volume after follow-through day
Stock market leaders have emerged in the IBD 50 after the S&P 500's follow-through day, many with strong up/down volume ratios.
The inflammatory bowel disease therapy succeeded in its first major testing, setting up a competition with several large drugmakers.
Conventional wisdom holds that nonsteroidal anti-inflammatory drugs (NSAIDs) can trigger disease flares in patients with ...
A common vitamin may help calm gut inflammation in Crohn’s and colitis, reshaping how doctors approach treatment.
This is the reality for the nearly 3.1 million Americans living with inflammatory bowel disease (IBD), including Crohn’s ...
The therapy, which works similarly to Takeda’s blockbuster Entyvio, showed remission rates that suggest a “best-in-class” ...
A new study published today in Stem Cell Reports demonstrates how a human stem cell-derived model of the intestine can be used to identify potential therapies for inflammatory bowel disease (IBD), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results